{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:43:37Z","timestamp":1794559417818,"version":"4.9.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":3865,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1111\/j.1469-0691.2004.00758.x","type":"journal-article","created":{"date-parts":[[2004,4,26]],"date-time":"2004-04-26T12:25:50Z","timestamp":1082982350000},"page":"388-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":224,"title":["Tuberculosis in HIV-infected patients: a comprehensive review"],"prefix":"10.1016","volume":"10","author":[{"given":"L.","family":"Aaron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Calatroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"M\u00e9main","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bouchaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2004.00758.x_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0167-5699(98)01321-8","article-title":"Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria","volume":"19","author":"Ottenhoff","year":"1998","journal-title":"Immunol Today"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib2","first-page":"S19","article-title":"Pathophysiology and immunology of tuberculosis","volume":"14","author":"Marchal","year":"1997","journal-title":"Rev Mal Respir"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","article-title":"Current concepts. Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib4","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.159.6.2824","article-title":"Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV","volume":"159","author":"Garrait","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/ajrccm.151.1.7812542","article-title":"Accelerated course of human immunodeficiency virus infection after tuberculosis","volume":"151","author":"Whalen","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis. Estimated incidence prevalence and mortality by country. Who Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00002030-200205030-00013","article-title":"Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis","volume":"16","author":"Seng","year":"2002","journal-title":"AIDS"},{"issue":"suppl B","key":"10.1111\/j.1469-0691.2004.00758.x_bib8","first-page":"S115","article-title":"Tuberculosis and HIV: current status in Africa","volume":"11","author":"Raviglione","year":"1997","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib9","first-page":"75","article-title":"Risk factors for developing tuberculosis in HIV-1 infected adults from communities with a low or very high incidence of tuberculosis","volume":"23","author":"Wood","year":"2000","journal-title":"J AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib10","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bmj.311.7018.1468","article-title":"Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group","volume":"311","author":"Perneger","year":"1995","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib11","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0140-6736(02)09095-5","article-title":"HIV\/AIDS and the control of other infectious diseases in Africa","volume":"359","author":"Corbett","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/00002030-199312000-00005","article-title":"The mortality and pathology of HIV infection in a West Africa city","volume":"7","author":"Lucas","year":"1993","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib13","first-page":"59","article-title":"Epidemiology of HIV infection in sub-Saharan Africa","volume":"3","author":"Laurent","year":"2001","journal-title":"AIDS Rev"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib14","first-page":"23","article-title":"Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya","volume":"24","author":"Rana","year":"2000","journal-title":"J AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib15","first-page":"86","article-title":"Surveillance de la tuberculose en France","volume":"19","author":"Institut de Veille Sanitaire (IVS)","year":"1993","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib16","first-page":"207","article-title":"Surveillance du SIDA en France. Situation au 30 septembre 2001","volume":"47","author":"Institut de Veille Sanitaire (IVS)","year":"2001","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMoa012972","article-title":"Changes in the transmission of tuberculosis in New York city from 1990 to 1999","volume":"346","author":"Geng","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/339448","article-title":"Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000","volume":"34","author":"Leonard","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib19","first-page":"68","article-title":"Les cas de tuberculose d\u00e9clar\u00e9s en France 2000","volume":"16","author":"Decludt","year":"2002","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib20","first-page":"71","article-title":"Surveillance de la tuberculose \u00e0 bacilles multir\u00e9sistants en France en 1998","volume":"16","author":"Robert","year":"2002","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM199201233260404","article-title":"An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms","volume":"326","author":"Daley","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib22","first-page":"1479","article-title":"Tuberculosis in patients infected with the human immunodeficiency virus","volume":"17","author":"Perronne","year":"1988","journal-title":"Presse Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/ajrccm\/148.5.1292","article-title":"Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection","volume":"148","author":"Jones","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1086\/514546","article-title":"Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG)","volume":"25","author":"Perlman","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1378\/chest.106.3.684","article-title":"Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis","volume":"106","author":"Smith","year":"1994","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1164\/arrd.1987.135.4.875","article-title":"HTLV-III seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study","volume":"135","author":"Pitchenik","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-9343(92)90579-Z","article-title":"Tuberculosis meningitis in patients with and without human immunodeficiency virus infection","volume":"93","author":"Dube","year":"1992","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1148\/radiology.198.3.8628855","article-title":"Pulmonary tuberculosis: comparison of CT findings in HIV-seropositive and HIV seronegative patients","volume":"198","author":"Leung","year":"1996","journal-title":"Radiology"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2796.1994.tb00840.x","article-title":"Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases","volume":"236","author":"Bissuel","year":"1994","journal-title":"J Intern Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/archinte.1993.00410040062009","article-title":"Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection","volume":"153","author":"Bouza","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib31","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1164\/ajrccm\/140.6.1611","article-title":"Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in area endemic for AIDS","volume":"140","author":"Shafer","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1378\/chest.102.1.143","article-title":"The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection","volume":"102","author":"Salzman","year":"1992","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib33","first-page":"945","article-title":"Retrospective bacteriological study of mycobacterial infections in patients with acquired immunodeficiency syndrome","volume":"17","author":"Pangon","year":"1988","journal-title":"Presse Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1164\/ajrccm.153.5.8630609","article-title":"Clinical efficacy of the amplified Mycobacterium tuberculosis direct test for the diagnosis of pulmonary tuberculosis","volume":"153","author":"Bradley","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","article-title":"Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy","volume":"16","author":"Dean","year":"2002","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib36","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1164\/ajrccm.157.6.9707037","article-title":"Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis; initial report","volume":"157","author":"Tam","year":"1998","journal-title":"Am J Respir Crit Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib37","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(98)11467-8","article-title":"Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium","volume":"353","author":"Vernon","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/ajrccm.154.4.8887603","article-title":"Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection","volume":"154","author":"Chaisson","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib39","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/520275","article-title":"Evaluation of an intensive intermittent-induction regimen and short course duration of treatment for HIV-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical trials Group (ACTG)","volume":"26","author":"El-Sadr","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib40","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00002030-199510000-00011","article-title":"Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa","volume":"9","author":"Kassim","year":"1995","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJM199503233321204","article-title":"Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months","volume":"332","author":"Perriens","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archinte.1997.00440230105014","article-title":"Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients","volume":"157","author":"Pulido","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib43","first-page":"1","article-title":"Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib44","first-page":"185","article-title":"Prevention and treatment of tuberculosis among patients infected with human immuodeficiency virus: principles of therapy and revised recommendations","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00002030-199903110-00001","article-title":"The treatment of tuberculosis in HIV-infected persons","volume":"13","author":"Pozniak","year":"1999","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00002030-199408000-00010","article-title":"Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients","volume":"8","author":"Alwood","year":"1994","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib47","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1164\/ajrccm\/146.4.849","article-title":"Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality","volume":"146","author":"Nunn","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib48","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1164\/ajrccm.150.6.7952606","article-title":"Prospective evaluation of antituberculosis therapy in patients with HIV infection","volume":"150","author":"Jones","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib49","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00002030-200106150-00018","article-title":"Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin","volume":"15","author":"Moreno","year":"2001","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib50","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200241090-00004","article-title":"Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis","volume":"41","author":"Lopez-Cortes","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib51","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nm0796-760","article-title":"Ordered accumulation of mutations in HIV protease confers resistance to ritonavir","volume":"2","author":"Molla","year":"1996","journal-title":"Nat Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib52","first-page":"921","article-title":"Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-3542(97)00011-9","article-title":"Pharmacokinetic study of the interaction between rifabutin and delaverdine mesylate in HIV-1 infected patients","volume":"35","author":"Borin","year":"1997","journal-title":"Anti Viral Res"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib54","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/516146","article-title":"Rifampin monoresistant tuberculosis in New York City, 1993-1994","volume":"25","author":"Munsiff","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib55","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1164\/ajrccm.157.6.1576","article-title":"New tuberculosis drug development: how can we do better?","volume":"157","author":"O'Brien","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib56","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1164\/ajrccm.157.6.9712009","article-title":"Risk factors for rifampin mono-resistant tuberculosis","volume":"157","author":"Rizdon","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1164\/ajrccm.159.2.9805097","article-title":"Risk factors for rifampin-monoresistant tuberculosis: a case-control study","volume":"159","author":"Sandman","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib58","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1056\/NEJM199502023320518","article-title":"Drug malabsorption and resistance tuberculosis in HIV-infected patients","volume":"332","author":"Patel","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/106002809603000901","article-title":"Low antituberculosis drug concentrations in patients with AIDS","volume":"9","author":"Peloquin","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib60","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1164\/ajrccm.152.3.7663785","article-title":"Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis","volume":"152","author":"Nolan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib61","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0140-6736(93)91474-Z","article-title":"Increased recurrence of tuberculosis in HIV-1 infected patients in Kenya","volume":"342","author":"Hawken","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib62","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1164\/ajrccm\/144.4.750","article-title":"Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with 'standard' chemotherapy in Kinshasa, Zaire","volume":"144","author":"Perriens","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib63","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(00)02870-1","article-title":"Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial","volume":"356","author":"Fitzgerald","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib64","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(01)06712-5","article-title":"Godfrey\u2013Faussett. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers","volume":"358","author":"Sonnenberg","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib65","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/00002030-199908200-00015","article-title":"Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa","volume":"13","author":"Connolly","year":"1999","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib66","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/517636","article-title":"Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy","volume":"26","author":"Crump","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib67","first-page":"944","article-title":"Immune mediated 'HAART' attack during treatment for tuberculosis. Highly active antiretroviral therapy","volume":"3","author":"Kunimoto","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","article-title":"Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS","volume":"158","author":"Narita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib70","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(97)04352-3","article-title":"Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease","volume":"351","author":"Race","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib71","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1086\/515019","article-title":"High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors","volume":"27","author":"Martinez","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib72","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archopht.116.2.169","article-title":"Immune recovery vitritis associated with inactive cytomegalovirus retinitis","volume":"116","author":"Karavellas","year":"1998","journal-title":"Arch Opthalmol"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib73","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(96)11431-8","article-title":"Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy","volume":"349","author":"Jacobson","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib74","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002030-199902040-00005","article-title":"Immunopathology as a result of highly active antiretroviral therapy in HIV-1 infected patients","volume":"13","author":"Foudraine","year":"1999","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib75","series-title":"Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL","article-title":"Paradoxical reactions due to immune restoration during Cryptococcus neoformans infection in AIDS [abstract 674]","author":"Memain","year":"2001"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib76","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM200005113421907","article-title":"Drug therapy: prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection","volume":"342","author":"Kovacs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib77","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/00002030-199910220-00009","article-title":"Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis","volume":"22","author":"Gourevitch","year":"1999","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib78","first-page":"140","article-title":"Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis","volume":"2","author":"Jansa","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib79","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archinte.1996.00440080089010","article-title":"Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease","volume":"156","author":"Graham","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib80","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomized trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib81","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib82","first-page":"733","article-title":"Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in. American Thoracic Society\/CDC recommendation\u2014United States, 2001","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib83","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib84","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2004.00758.x_bib85","first-page":"385","article-title":"Preventive therapy against tuberculosis in people living with HIV","volume":"74","author":"World Health Organization\/UNAIDS","year":"1999","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1462824X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1462824X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:16:52Z","timestamp":1761117412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1462824X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S1198743X1462824X"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2004.00758.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis in HIV-infected patients: a comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1469-0691.2004.00758.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}